Sulemana Abdul Samed, widely regarded as Ghana's tallest man, died on Monday, July 27, 2026, at the age of 33. Yahoo News Canada; Legit.ng

Known locally as "Awuche" (also spelled "Ache"), Samed lived in Gambaga, a town in Ghana's North East Region. The BBC, which profiled him in January 2023, described him as a notably tall man whose stature had drawn national attention. BBC

A resident of Gambaga named Kudus told the BBC that Samed died on a Monday morning at the hospital. According to Kudus, doctors had said Samed was responding well to treatment before his sudden death. The BBC article does not specify a calendar date of death, age at death, or birth year; the date of July 27 and age of 33 come from separate reporting by Yahoo News Canada and Legit.ng. BBC; Yahoo News Canada

Conflicting Height Reports

Samed's height was a matter of some discrepancy across sources. The BBC's July 2026 obituary reported his height as 7 feet. A 2022 BBC Pidgin article, by contrast, had reported his height as 9.6 feet (approximately 2.92 meters), a figure that circulated widely in Ghanaian and international media. The reasons for the substantial difference between the two BBC figures are not explained in either article. BBC; BBC Pidgin

Medical History

Samed's medical history was central to his public story. He had Marfan syndrome, a genetic condition affecting the body's connective tissues — the structures that hold the body together, including blood vessels, bones, and cartilage. He was also diagnosed with gigantism in his 20s, a disorder caused by excessive production of growth hormone, typically by the pituitary gland. He began growing taller than his peers at age 22. BBC

The onset of symptoms occurred while Samed was working at a butcher's shop in Accra, Ghana's capital. He first noticed changes including his tongue expanding to the point of causing breathing difficulty. BBC

In later years, Samed developed sores on his legs. According to Kudus's account to the BBC, these were not a direct result of Marfan syndrome but a likely complication of his overall condition. BBC

Public Appeals and Financial Struggles

Samed's medical needs had been a matter of public concern in Ghana for years before his death. In April 2021, MyJoyOnline reported that he was 27 years old and that his family had appealed for financial support to cover his medical treatment. A subsequent BBC profile published around January 2023 listed his age as 29. MyJoyOnline; BBC

The age trajectory across sources — 27 in 2021 and 29 in early 2023 — is consistent with a birth year of approximately 1992 to 1993, which would align with the reported age of 33 at death in July 2026.

International Attention

Samed's height also attracted international attention beyond Ghana. In January 2023, MyJoyOnline reported that an Ethiopian man named Negewo Jima had posted on Facebook claiming to be taller than Samed, though no formal measurement comparison was conducted. MyJoyOnline

The Broader Health Context

The broader context here involves the intersection of rare endocrine and connective tissue disorders with the realities of healthcare access in lower-income settings. Marfan syndrome, which affects approximately 1 in 3,000 to 5,000 people globally, can produce cardiovascular complications, skeletal abnormalities, and, in some cases, accelerated growth when combined with conditions like gigantism, which involves excessive pituitary growth hormone production. The leg sores Samed experienced may reflect vascular or lymphatic complications, which are known to occur in patients with severe Marfan phenotype or related connective tissue disorders. These details are medical context; the specific clinical course of Samed's case is known only from the BBC's reporting of Kudus's account.

The financial appeal reported by MyJoyOnline in 2021 points to a structural challenge: specialized endocrinological and cardiovascular care for complex syndromic conditions is limited in many parts of sub-Saharan Africa, and patients with rare disorders often depend on a combination of public health infrastructure and charitable support. Samed's case drew public attention partly because of his unusual stature, but the underlying healthcare access questions are shared by many patients with rare conditions across the region.

Samed's death, reported as sudden despite apparent improvement under treatment, raises questions about cardiovascular risk in Marfan syndrome, where aortic dissection and rupture are leading causes of premature mortality. Without clinical details from his medical team, the specific cause of death remains unreported.